ProfessionalDiscontinued

Psilocybin Assisted Therapy for Existential Distress in Cancer Patients by Jeff Guss, MD

This course covers psilocybin-assisted therapy for existential distress in cancer patients, including the study rationale, participant selection, preparation, dosing-session support, and integration. It also discusses the historical and cultural context of psychedelics and the role of the therapist in supporting inner-

Provider

English

Details

000 years

Enrollment

Price on request
This course is currently marked as discontinued.

Course Overview

This course examines psilocybin-assisted therapy for existential distress in cancer patients. It explains how the study was shaped by the concept of existential distress, including how participants were selected, how preparation was structured, and how integration was approached after the dosing session. The content also reviews the broader history of psychedelics in culture, including their long-standing use in indigenous and religious contexts. It presents existential distress as a response to cancer diagnosis marked by fear, sadness, loss of meaning, and questioning of life’s purpose. The course describes the therapist’s role as supportive and minimally directive during the session, with emphasis on helping participants remain with their inner experience. It also addresses post-session integration and the relevance of transpersonal psychology in spiritual and existential work.

Who is this for?

Clinicians, therapists, and mental health professionals interested in psychedelic-assisted therapy, cancer-related existential distress, and integration work.

About the Provider

Educational platform co-founded by Dr. Will Van Derveer and Keith Kurlander that trains therapists, physicians, and nurses in psychedelic-assisted therapy through a year-long online program taught by 50+ experts including Robin Carhart-Harris, Michael Pollan, and Rick Doblin. IPI's curriculum covers evidence-based protocols for PTSD, depression, and anxiety, and partners with the Usona Institute and MAPS to prepare clinicians for emerging MDMA- and psilocybin-assisted treatments.

View IPI profile

Course Details

  • PricePrice on request
  • Lifecycle statusDiscontinued
  • Skills
    IntegrationPsilocybin TherapyUnderstanding existential distress in cancer careExplaining psilocybin-assisted therapy structureSupporting minimally directed psychedelic sessionsFacilitating post-session integrationInterpreting cultural and historical context of psychedelicsRecognizing the role of transpersonal psychologyUnderstanding psilocybin-assisted therapy in cancer careRecognizing existential distress in patients with cancerParticipant selection and preparationSupporting minimally directive dosing-session workApplying transpersonal psychology conceptsRecognizing existential distress in cancer patients
  • Categories